Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
Subhrangshu Guhathakurta, Min Kyung Song, Sambuddha Basu, Goun Je, Ana Clara Cristovao, Yoon-Seong Kim
Int Neurourol J. 2022;26(Suppl 2):S85-93.   Published online 2022 Nov 30
DOI: https://doi.org/10.5213/inj.2222206.103
Citations to this article as recorded by
  Crossref logo
Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies
Rosaria Meccariello, Gian Carlo Bellenchi, Salvatore Pulcrano, Sebastian Luca D’Addario, Domenico Tafuri, Nicola B. Mercuri, Ezia Guatteo
Frontiers in Cellular Neuroscience.2024;[Epub]     CrossRef
Targeting epigenetic modifications in Parkinson's disease therapy
Dan Zhang, Jifa Zhang, Yuxi Wang, Guan Wang, Pan Tang, Yun Liu, Yiwen Zhang, Liang Ouyang
Medicinal Research Reviews.2023; 43(5): 1748.     CrossRef
Role of epigenetic modifications in Parkinson's disease
Jian-Nan Zhang, Qian Li, Fei Yang
Epigenomics.2023; 15(10): 573.     CrossRef
Epigenetic Dysfunction of Neurodegenerative Diseases, MeCP2 and More
Heh-In Im
International Neurourology Journal.2022; 26(Suppl 2): S83.     CrossRef
Looking Forward to Saying Goodbye to COVID-19 and a Step Forward
Young Sam Cho
International Neurourology Journal.2022; 26(4): 259.     CrossRef